September 15th 2023

DAO deficiency Licenses

Uruguay and Panama, new countries in Latin America with healthcare professionals specialized in DAO deficiency

Exciting News from the International Institute of DAO Deficiency: Our licensing program now has new referent clinicians who are receiving ongoing training every month. This is essential to ensure that our patients receive the best possible care and support.


July 12th 2023

Journey of DAO deficiency

Lic. Ignacia Pagliettini at the UCN

The Universidad Católica del Norte (UCN), in Chile, will give a free course about DAO deficiency and Histamine Intolerance for its nutrition students next Friday, July 21, by Lic. Ignacia Pagliettini. To attend the Journey it is necessary to fill out the following inscription.


June 9th 2023

New study published

Cumulative effect of AOC1 gene variants on symptoms and pathological conditions in adult women with fibromyalgia: a pilot study

A co-authored publication of the International Institute of DAO deficiency has been published in Frontiers in Genetics. The results show that fibromyalgia symptoms measured using the FIQ tend to increase with the number of risk alleles and that the intensity of dry skin and low stool consistency may be associated with an increase in the number of these alleles. Download Article


June 5th 2023

DAO deficiency Licenses

A new pre-registration process starts for the Institute's Licensing Program.

The International Institute of DAO deficiency launches its 2nd call for pre-registration for those healthcare professionals who want to specialize in DAO deficiency and be part of an international professional community. Some of the new locations with available vacancy are in Spain, Mexico, Uruguay and Colombia, among others. Save the dates: 15, 16 and 22 of September. Application Form

DAO Argentina ok

May 16th 2023

TV interview about DAO deficiency

Lic. Pilar de León in Medical TV

In the following link you will find the complete interview to Lic. Pilar de León, on Medical TV. She is one of the accredited dietitians of the Institute, from Salta (Argentina). In the interview Pilar talks about what DAO deficiency is, how it is diagnosed and which treatment is the most appropriate to apply.

April 15th 2023

VI Congress AND 2023

The Spanish Academy of Nutrition and Dietetics organizes its VI Congress and will take place on November 24th and 25th in Barcelona, Spain

Under the motto “Nutrition with the heart: Plant-Based Diets in professional practice”, the VI Congress of the AND will bring together Registered dietitians from Spain to share current knowledge. The International Institute of DAO deficiency will be present with an oral communication on DAO deficiency and genetics. The abstract acceptance process ends on April 2.

February 17th 2023

DAO deficiency Licenses

Argentina and Chile, the first countries in Latin America with healthcare professionals specialized in DAO deficiency

The International Institute of DAO deficiency, through its Licensing Program, already has collaborating doctors and nutritionists in Spain, Argentina, Chile and France. By the end of 2023 there will be more openings in new cities in Europe and Latin America.

February 1st 2023

45th ESPEN Congress

The European Society for Clinical Nutrition and Metabolism organizes its 45th Congress on September 11-14 in Lyon, France

The ESPEN Congress is one of the most recognized and expected in Europe where a multitude of professionals linked to the world of nutrition share the latest published scientific advances. Last year it was held in Vienna and this year it is Lyon. The abstract acceptance process ends on April 10.

January 16th 2023

Scientific evidence

2022 has been the year with the highest number of scientific articles published on DAO deficiency and histamine intolerance in history

China, Spain and Germany are some of the countries that invest the most budget in the investigation of the DAO deficiency. This fact accelerates the interest and need, both publicly and privately, to broaden knowledge and create new spaces for the specialty of this metabolic disorder that affects 15% of the population.